Physician profile
Joshua D Patton
NPI 1033670617
$4,295.42
in general payments reported to CMS, 2019-2025
20 companies · $364 in 2025
The $364 reported for 2025 was more than what 80% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2022: $1,677 · 2023: $335 · 2024: $1,783 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,245 · Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,245.38 |
| Food and Beverage | $1,236.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,418.95 | 2022-2024 | |
| Peerless Surgical INC. | $1,162.59 | 2023-2025 | |
| Amgen INC. | $736.08 | 2022-2025 | Evenity, Prolia, Prolia |
| Abiomed | $172.87 | 2024 | Impella |
| Allergan, INC. | $136.85 | 2019 | |
| Djo, LLC | $108.00 | 2024 | Procare |
| Pacira Pharmaceuticals Incorporated | $88.48 | 2023 | Iovera |
| Hydrocision, INC. | $86.00 | 2025 | Tenjet |
| Inari Medical, INC. | $77.03 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mvp Orthopedics INC | $72.41 | 2023 | |
| Lilly USA, LLC | $48.07 | 2024 | Jardiance |
| Glaxosmithkline, LLC. | $44.41 | 2025 | Trelegy Ellipta |
| Fidia Pharma USA INC. | $21.67 | 2025 | Hymovis |
| Bioventus LLC | $21.39 | 2023 | Durolane |
| Bayer Healthcare Pharmaceuticals INC. | $19.97 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.41 | 2025 | |
| Pfizer INC. | $16.96 | 2024 | |
| Exact Sciences Corporation | $16.05 | 2024 | Cologuard Collection Kit |
| Ferring Pharmaceuticals INC. | $15.81 | 2023 | Euflexxa |
| Merck Sharp & Dohme LLC | $13.42 | 2023 | Vaxneuvance, Vaxelis, Rotateq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.